Home » Archive

Articles in the Legal Category

Legal »

[2 Jul 2009 | No Comment | ]

In 1957, Govt. of India appointed Justice N. Rajagopala Ayyangar examine and review the Patent law in India who submitted his report September 1959 recommending the retention of Patent System despite shortcomings. The Patent Bill, 1965 based mainly on his recommendations incorporating a few changes, in particular relating to Patents for food, drug, medicines, was introduced in the lower house of Parliament on 21st September, 1965. The bill was passed by the Parliament and the Patents Act 1970 came into force on 20th April 1972 along with Patent Rules 1972. …

Legal »

[1 Jul 2009 | One Comment | ]

The last few years have seen a steady increase in the number of NRIs returning to India. The web is seeing an increase in web portals designed to find jobs for these Indians in US, who consider working in India more attractive as it takes care of their sentimental needs while they settle down in a comfortable job and lifestyle. Indians returning to India need to keep their minds open and be ready to accept everything that comes their way as far as challenges are concerned.
If they are hoping to …

Legal »

[1 Jul 2009 | No Comment | ]

The judicial system of India is basically made up of the supreme court of India which stands at the apex of the entire country’s hierarchy. There are a total of twenty one high courts which are at the top of the hierarchy for every state. The India high court has a jurisdiction over the particular state or over the group of union territories and states or even over union territory. Below the Indian High Court there is the hierarchy of subordinate courts which are called as criminal courts, family courts, …

Legal »

[17 Jun 2009 | No Comment | ]

Data exclusivity refers to a practice whereby, for a fixed period of time, test and other data provided to the drug regulatory authority (“DRA”) of a country (to demonstrate the efficacy and safety of a medicinal product [1]) in order to obtain an authorization to place the product on the market in that country, are not allowed to be used to register a therapeutically equivalent generic version of that product. Oftentimes, this data arises out of many years of research and clinical trials and is very expensive for the originator …